Immuron (IMRN) Depreciation & Amortization - Total (2016 - 2018)
Immuron (IMRN) recorded quarterly Depreciation & Amortization - Total of -$2646.0 in Q4 2018, down 49.11% quarter-over-quarter from -$1774.6 in Q4 2017, and down 49.11% on a YoY basis from -$5199.2 in Q4 2017.
Immuron (IMRN) Depreciation & Amortization - Total (2016 - 2018) Analysis & Trends
Immuron's Depreciation & Amortization - Total history runs 3 years deep, the most recent figure standing at -$2646.0 for Q4 2018.
- In Q4 2018, Depreciation & Amortization - Total fell 49.11% year-over-year to -$2646.0; the TTM figure through Jun 2020 stood at -$2646.0 (changed 0.0% YoY), while the FY2025 annual figure was $32204.2, up 6.79% from the prior year.
- Depreciation & Amortization - Total was -$2646.0 for Q4 2018 at Immuron, down from -$1774.6 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of -$1489.1 in Q4 2016 to a low of -$2906.2 in Q2 2016.
- Historically, Depreciation & Amortization - Total has averaged -$2204.0 across 3 years, with a median of -$2210.3 in 2018.
- The sharpest annual moves came in 2017 and 2018: Depreciation & Amortization - Total declined 19.17% in 2017, then slumped 49.11% in 2018.
- A 3-year view of Depreciation & Amortization - Total shows it stood at -$1489.1 in 2016, then decreased by 19.17% to -$1774.6 in 2017, then plunged by 49.11% to -$2646.0 in 2018.
- The last three Depreciation & Amortization - Total figures came in at -$2646.0 (Q4 2018), -$1774.6 (Q4 2017), and -$1489.1 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -2,646.00 |
| Dec 31, 2017 | -1,774.56 |
| Dec 31, 2016 | -1,489.11 |
| Jun 30, 2016 | -2,906.17 |